Li and Dragan Named to Lead ACT

Louisville, KY. CreoSalus, Inc. announced Charles Li has been named President/CEO of its  Advanced ChemTech subsidiary. Advanced ChemTech is a respected supplier of fine chemicals to the pharmaceutical industry. Charles has been with Advanced ChemTech for 10 years most recently in the role of international business manager. In this role, Charles was instrumental in marketing the Tetras, the industry’s most advanced automated peptide synthesizer, and expanding Advanced ChemTech’s international footprint. In the fall of 2011 Charles was made acting President/CEO. Under his leadership the business has grown both revenues and profits as well as improved relationships with key customers.

In addition, CreoSalus has named Dragan Ristic, Director of Chemical Operations. Dragan has been with Advanced ChemTech a total of 6 years. As Director of Chemical Operations, Dragan is responsible for process development and production of amino acid derivatives, resins and reagents. Prior to joining Advanced ChemTech, Dragan worked at deCODE Genetics for 10 years and AstraZeneca/Bosnalijek for 11 years providing a leadership role in the organic synthesis of active pharmaceutical ingredients.

CreoSalus is a privately held Louisville, Kentucky based life-sciences company with businesses specializing in the development and manufacturing of finished drugs (Thorn BioScience), human medical devices (Occam Design), and fine chemicals (Advanced ChemTech). CreoSalus is Latin for ‘creating good health.’